Skip to main content
. 2014 May 2;8:421–429. doi: 10.2147/DDDT.S63320

Table 1.

Numbers of MNCs and fibroblasts in the study groups

Study group Number of MNCs (mean ± SD) Number of fibroblasts (mean ± SD)
Control (n=7) 2.75±1.16 2.00±0.53
Sham (n=7) 24.71±7.36a 2.85±0.37a
MMC (n=7) 10.42±4.27a,b 1.57±0.53b
Infliximab (n=7) 5.25±1.28a,b 1.37±0.51b

Notes:

a

Control group compared with sham group (P<0.01);

b

treatment groups compared with sham group (P<0.01).

Abbreviations: MMC, mitomycin-C; MNCs, mononuclear cells; SD, standard deviation.